top of page

February 2025: Healthcare M&A Snapshot

  • Eclipse Corporate Finance
  • Mar 5
  • 2 min read
A summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in February 2025.

View our summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in February 2025 below.



Notable Sector Deals: February 2025


Liva Healthcare’s acquisition of Momenta


  • A complementary deal for Liva Healthcare with the acquisition of digital lifestyle service provider Momenta

  • Momenta provides digital and in-person healthy lifestyle programmes to the NHS and local authorities across the UK, for the prevention of chronic conditions such as type 2 diabetes

  • Liva is a digital health technology platform with human-led therapeutic intervention programmes for lifestyle-related chronic diseases

  • The deal will cement Liva’s position as one of the largest providers of healthy lifestyle programmes to the NHS and follows its latest funding round led by Danish family investment group, IBL Group


Acquisition of Hospital Services by Asker Healthcare Group


  • A strategic acquisition for Asker Healthcare Group, with the bolt-on of Belfast-based Hospital Services Limited (HSL)

  • HSL is a specialist distributor of diagnostic medical devices to public and private hospitals across RoI, Northern Ireland, and Great Britain

  • Asker Healthcare Group is a European consolidator of medical product businesses, completing 50 acquisitions since 2019

  • The transaction provides a successful exit for Foresight Group, after driving HSL’s growth to revenues of c.£60m since investing in 2015

  • The deal highlights continued activity in the medical products market, with large scale operators deploying buy and build strategies


Audiological Science MBO supported by YFM


  • Another successful healthcare deal for YFM, backing the management buy-out of Audiological Science with a £12.4m investment

  • Audiological Science provides hearing tests, hearing aids and a wider range of audiology services to both NHS and private-pay patients

  • As a specialist community-based provider, the business plays a crucial role in supporting the NHS in its ambition to take low-complexity ear care out of hospital settings, reducing waiting lists and freeing up hospitals to focus on more complex cases

  • The deal highlights continued private equity interest in high quality businesses providing community-based services to the NHS


Acquisition of Apple House by National Care Group


  • A further acquisition for specialist care consolidator, National Care Group, with the addition of specialist accommodation provider Apple House

  • Apple House operates across six locations in the Dorset area, offering personalised support for adults with learning disabilities and associated needs

  • The acquisition will strengthen National Care Group’s care provision in the region and allow collaboration with its existing services

  • Demand for high-quality, person-centred adult social care continues to grow, with providers focusing on expanding services to meet the needs of individuals, families, and commissioning bodies


Healthcare Market Activity: February 2025


Private Equity Activity


Sub-sector

Target

Acquirer / Investor

Exiting PE

Clinical Services

Audiological

Science

YFM

N/A

Clinical Services

Momenta

Liva Healthcare(IBL Group)

N/A

Medical Equipment

HSL

Asker Healthcare

Foresight

Pharma

ALTURiX

Kelso Pharma (Apposite)

N/A


Venture Capital Activity


Target

Description

Lead Investor

Investment

CareLoop

Digital therapeutics for mental health

Praetura

£1.8m

IQ Endoscopes

Single use, flexible endoscopes

BGF

£5.2m

Level Zero Health

Remote hormone monitoring

Redalpine

£5.5m

OrganOx

Medical technology used in organ transplants

HealthQuest  Capital

$142m

Pill Connect

Device to track medicine consumption

Praetura

N/D



Eclipse Corporate Finance Limited is a limited company registered in England & Wales (registered number 11791669)

The company is regulated by the Institute of Chartered Accountants of Scotland for a range of investment business activities 

  • LinkedIn
bottom of page